|
RALGPS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.33810004690582E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
3.062000E-01 |
| Stage1-vs-Stage3 |
2.155600E-03 |
| Stage1-vs-Stage4 |
1.798080E-04 |
| Stage2-vs-Stage3 |
1.442830E-03 |
| Stage2-vs-Stage4 |
1.970970E-04 |
| Stage3-vs-Stage4 |
2.120400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.08700000001072E-07 |
| Normal-vs-Asian |
6.91757762183443E-12 |
| Caucasian-vs-AfricanAmerican |
4.701400E-01 |
| Caucasian-vs-Asian |
2.019000E-01 |
| AfricanAmerican-vs-Asian |
8.477800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
6.632200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.52570000025543E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.716400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.164200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.515800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.506000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.348450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.318760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.00599999997009E-07 |
| Classical-VS-Follicular |
5.382100E-04 |
| Classical-VS-Other |
9.871800E-01 |
| Classical-VS-Normal |
1.62725388719309E-12 |
| Tall-VS-Follicular |
9.4480978596323E-11 |
| Tall-VS-Other |
1.083950E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.676600E-01 |
| Follicular-VS-Normal |
2.57059999952958E-07 |
| Other-VS-Normal |
2.402500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.55111512312578E-16 |
| N0-vs-N1 |
1.232340E-02 |
|
|
